Real-world evidence in a large cohort comparing FAPI and FDG PET/CT for hepatopancreatobiliary cancer diagnosis
European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8246-8261
DOI: 10.1007/s00259-026-08112-w ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 12.08.2026. Verfasst von Suneetha Batchu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Asian Institute of Gastroenterology (AIG Hospitals), Hyderabad, India. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Liver Neoplasms, Pancreatic Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Diagnosing hepatopancreatobiliary (HPB) malignancies remains challenging. Conventional imaging often lacks sensitivity for occult nodal and distant metastases, and FDG PET/CT has variable performance due to low uptake in several tumour subtypes and false-positive uptake in inflammation. Fibroblast activation protein inhibitor (FAPI) PET/CT has emerged as a promising alternative. This study compared the diagnostic accuracy of FDG PET/CT, FAPI PET/CT, and a dual-tracer approach in suspected HPB malignancies.
Methods
This retrospective analysis included patients who underwent both [ 18 F]FDG and [ 68 Ga]Ga-FAPI-46 PET/CT for suspected HPB cancer, including cholangiocarcinoma, gallbladder carcinoma, pancreatic carcinoma, periampullary carcinoma, and hepatocellular carcinoma. Histopathology and/or clinical follow-up served as reference standard. FDG PET/CT classification used an SUV max cut-off derived from receiver-operating characteristic analysis, while FAPI PET/CT classification followed expert clinical interpretation. Sensitivity, specificity, and accuracy metrics were compared using paired statistics.
Results
176 patients were included. FAPI PET/CT demonstrated higher sensitivity than FDG PET/CT (93.0% vs. 76.5%, p = 0.002). Primary tumour diagnostic accuracy was 78.9% for FAPI versus 68.3% for FDG ( p = 0.021). A dual-tracer approach did not outperform FAPI (76.7% vs. 78.9%, p = 0.711). For nodal disease, FAPI showed 86.8% diagnostic accuracy, compared with 71.1% for FDG ( p = 0.004), driven by higher specificity. For distant metastases, accuracy was 83.9% for FAPI versus 80.0% for FDG ( p = 0.625).
Conclusion
FAPI PET/CT outperformed FDG PET/CT in this retrospective analysis, with dual-tracer imaging offering no additional benefits. These results show great promise for clinical application of FAPI PET/CT for the detection of HPB tumours and their metastases to be confirmed by independent prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Asian Institute of Gastroenterology (AIG Hospitals), Hyderabad, India.
- Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands. m.m.k.veenstra@erasmusmc.nl.
- , Rotterdam, 3015 GD, The Netherlands. m.m.k.veenstra@erasmusmc.nl.
- Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands.
- Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands.
- Department of Gastroenterology, Asian Institute of Gastroenterology (AIG Hospitals), Hyderabad, India.
Zitieren
APA
Batchu, S., Veenstra, M. M. K., de Jong, D. M., Jayanthi, M. R., Vegt, E., Memon, S. F., Tyagi, A., Bos, D., Lakhtakia, S., Bruno, M. J., Reddy, D. N., Rughwani, H., & Thomeer, M. G. J. (2026). Real-world evidence in a large cohort comparing FAPI and FDG PET/CT for hepatopancreatobiliary cancer diagnosis. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8246-8261. https://doi.org/10.1007/s00259-026-08112-w
Vancouver
Batchu S, Veenstra MMK, de Jong DM, Jayanthi MR, Vegt E, Memon SF, et al. Real-world evidence in a large cohort comparing FAPI and FDG PET/CT for hepatopancreatobiliary cancer diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8246-8261. doi:10.1007/s00259-026-08112-w
BibTeX
@article{Batchu2026,
author = {Batchu, Suneetha and Veenstra, Mara M K and de Jong, David M and Jayanthi, Mohan Roop and Vegt, Erik and Memon, Sana F and Tyagi, Abhishek and Bos, Daniel and Lakhtakia, Sundeep and Bruno, Marco J and Reddy, D Nageshwar and Rughwani, Hardik and Thomeer, Maarten G J},
title = {Real-world evidence in a large cohort comparing FAPI and FDG PET/CT for hepatopancreatobiliary cancer diagnosis},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {13},
pages = {8246--8261},
doi = {10.1007/s00259-026-08112-w}
}
EUVIMED